Recombinant CD4 (Zanolimumab Biosimilar) antibody

Catalog No. ABIN7487876

The Mammalian Cells Monoclonal anti-CD4 (Zanolimumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect CD4 (Zanolimumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD4 (Zanolimumab Biosimilar) antibody (ABIN7487876)

Target: CD4 (Zanolimumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This CD4 (Zanolimumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-CD4 (Zanolimumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Zanolimumab Biosimilar - Anti-CD4 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD4 (Zanolimumab Biosimilar)

Target: CD4 (Zanolimumab Biosimilar)

Target Type: Biosimilar

Background: HuMax-CD4